Английская Википедия:Bermekimab
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
Bermekimab[1] (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A).[2] Шаблон:As of, bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer[3] and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis.[4]
Bermekimab is being developed by XBiotech Inc.[5]
References
Шаблон:Monoclonals for immune system Шаблон:Antineoplastic-drug-stub